ライフサイエンスコーパス: improvement

1 provides resources for spinach research and improvement.

2 fective and demonstrate significant clinical improvement.

3 nt comparative genomics studies and cucurbit improvement.

4 d endogenous OXT secretion may underlie this improvement.

5 sted (1 lux), demonstrating maximum possible improvement.

6 y of clinical trials, there is much room for improvement.

7 not significantly associated with a clinical improvement.

8 he Harrell C-index, and net reclassification improvement.

9 within the CNS and failed to drive clinical improvement.

10 g supply risk as the next best option, yield improvement.

11 ovement, and the remaining 34.9% had a large improvement.

12 rovided K, which also played a role in yield improvement.

13 cusing on diagnosis, treatment, and practice improvement.

14 id defervescence (median, 4 hr) and clinical improvement.

15 nd structural insights for further inhibitor improvement.

16 % response rate leaves much room for further improvement.

17 od, along with future directions for further improvements.

18 rmed to classify subjects with good glycemic improvements.

19 or rule-in categories: Net Reclassification Improvement +0.149 versus hs-cTnT, +0.235 versus hs-cTnI

20 for not worsening, 0.68 for at least a small improvement, 0.69 for at least a moderate improvement, a

21 letters for >/=3-step improvement, >/=2-step improvement, 1-step improvement, and no DRSS change, res

22 in QoL, 9.2% had no change, 9.2% had a small improvement, 13.5% had a moderate improvement, and the r

23 S [clinical improvement (8/12); radiological improvement (2/12); clinical worsening on discontinuatio

24 nstrated significant clinical and histologic improvement 3 d after the initiation of therapy, at whic

25 YAG laser group reported greater symptomatic improvement (54%) than controls (9%) (difference, 45%; 9

26 but not universal in non-CLIPPERS [clinical improvement (8/12); radiological improvement (2/12); cli

27 nference is a common educational and quality improvement activity performed in cardiac catheterizatio

28 otal occlusions (CTOs) and predictors of its improvement after CTO percutaneous coronary intervention

29 tion (logMAR), P < 0.001), greater mean BCVA improvement after surgery (-0.50 vs. -0.32 logMAR, P < 0

30 de higher category-free net reclassification improvement among participants who experienced an ASCVD

31 The overall net reclassification improvement and integrated discrimination improvement we

32 Remission was defined by symptom improvement and less than 15 eosinophils/high-power fiel

33 physiologic benefits translate into clinical improvement and outweigh the risk of transfusion.

34 motion and preoperative exercise had no pain improvement and reduction in opioid consumption: for con

35 and developed a predictive model of reliable improvement and reliable recovery.

36 of water to the reaction showed a remarkable improvement and the isomerization occurred at ambient te

37 has been used to address such questions, but improvements and debate in study design, model evaluatio

38 ll improvement, 0.69 for at least a moderate improvement, and 0.73 for predicting a large improvement

39 p improvement, >/=2-step improvement, 1-step improvement, and no DRSS change, respectively) compared

40 ad a small improvement, 13.5% had a moderate improvement, and the remaining 34.9% had a large improve

41 Further development and improvement are necessary to achieve the ideal of a noni

42 rge-scale GWAS of lipids and show that these improvements are largely sustained in real data.

43 aClip procedure are associated with clinical improvement as measured by 6MWT.

44 the default mode network predicted clinical improvement, as did more positive amygdala-to-ventromedi

45 Despite treatment improvements, associated renal lesions - congenital dysp

46 epolizumab versus placebo showed significant improvements at week 24 from baseline in SGRQ total scor

47 are beneficial to the mechanical flexibility improvement but also contribute to sunlight harvesting e

48 imental results show significant performance improvement by the CNN model over HIST in both classific

49 h communities emerged: epidemiology, quality improvement, cognitive systems engineering (CSE), and ap

50 With this improvement comes the ability to deploy E-AB sensors dir

51 nM, which corresponds to a 120-fold affinity improvement compared to the parent molecule.

52 roup (n = 168) showed a significantly better improvement compared with the waiting group (n = 147) in

53 cortices also correlated with motor function improvement, consistent with the increased white matter

54 Third, neighborhood improvement correlates positively with physical proximit

55 Such improvements could lead to more accurate disease staging

56 Quality improvement efforts should shift focus from individual m

57 onse and immunity, and we highlight how such improvements enable a greater understanding of the patho

58 c factors resulted in a net reclassification improvement for BE of 3.0% and for EAC of 5.6%.

59 We see this absolute improvement for up to 50% absorption, with a maximum obs

60 to identify high-priority areas for quality improvement from a population perspective.

61 ompression ratio) result in fuel consumption improvements from a fleet-wide mean of 5.6 L/100 km in 2

62 Within-group effect sizes demonstrated improvements from baseline to postassessment for the SHU

63 14.2, +11.3, and +11.2 letters for >/=3-step improvement, >/=2-step improvement, 1-step improvement,

64 Patients with DRSS stability or improvement had greater mean BCVA letter score changes (

65 tiation of universal NBS for CF, significant improvement has occurred in nutritional status, with nor

66 Yield improvement has progressed slowly, especially in drought

67 The improvements have been assessed over a set of diverse pr

68 Exercise-induced cognitive improvements have traditionally been observed following

69 mization, wherein >/=10-, 100-, or 1000-fold improvement in a variety of key pharmacological paramete

70 We observed some improvement in accrual to adjuvant trials but worsening

71 Covariate associated with significantly less improvement in ACT scores was obstructive sleep apnea (P

72 between switching to an employment model and improvement in any of 4 primary composite quality metric

73 -conserving therapy, we found no significant improvement in BCSS or OS for women undergoing CPM (BCSS

74 Baseline DRIL predicted 8-month improvement in BCVA (point estimate, 0.03; 95% CI, 0.01-

75 d- and-final part proposes ideas for further improvement in blue phase III technology to make it feas

76 ugation (MWL-AUC) experiments, demonstrating improvement in both the spectral performance and UV capa

77 Such key improvement in BRET measurement paves the way for the si

78 The improvement in catalytic performance is due to the activ

79 te recovery from AKI, and promote functional improvement in chronic nephropathies.

80 There was no evidence of improvement in complete response within 1 year reported

81 months after T-ionto CL, though the average improvement in corneal topography readings was slightly

82 ctacular, and unexpected, order of magnitude improvement in creep life of alloys upon adding small am

83 Moreover, for concave bending, a significant improvement in detection signal intensity (14.5% enhance

84 There is substantial room for improvement in diet quality in all sociodemographic subg

85 The post-dispersion treatment shows an improvement in directional thermal conductivity of the c

86 g anti-VEGF treatment for DME may experience improvement in DR severity.

87 with ranibizumab experienced 1-step or more improvement in DRSS from baseline to month 24; 40.0% had

88 o impact on the ability to achieve >/=2-step improvement in DRSS score.

89 mpared with radiotherapy alone, with minimal improvement in dysphagia progression-free survival and o

90 ng the course of follow-up, those who had an improvement in EF to >35% accrued a similar relative red

91 dom-effects model demonstrated a significant improvement in endothelial function following anti-TNF-a

92 Additionally, those patients with improvement in epiphora had a significantly smaller preo

93 CSWB-treated samples showed a significant improvement in erythrocyte morphology compared to untrea

94 nt with CN-105 was associated with a durable improvement in functional outcomes as assessed by Rotaro

95 of a gluten-free diet associated with small improvement in gastrointestinal symptoms compared with n

96 However, significantly more improvement in hsCRP (P <0.05) and a statistically compa

97 The improvement in image quality and diagnostic accuracy of

98 post-transplant eGFR will require sustained improvement in immunosuppression and other aspects of po

99 Significant improvement in ion abundance and less chemical backgroun

100 Improvement in left ventricular ejection fraction (EF) t

101 d inversely to baseline SVI and demonstrated improvement in LF only (3 +/- 6 ml/m(2); p = 0.02).

102 ased immunoassay and demonstrate a 1300-fold improvement in limit of detection compared to a standard

103 A two-order improvement in LOD is obtained as compared to the recent

104 To compare improvement in long-term prognostication of incident CHD

105 uced risk of repeat revascularization and an improvement in long-term survival and should be consider

106 letion of an NMES protocol, but there was no improvement in MCT performance.

107 In all 4 cohorts, there was a 3- to 5-letter improvement in mean visual acuity over the 3 months afte

108 ext-generation sequencing data and continual improvement in measures of environmental exposures impli

109 tumor penetration and resulted in twice the improvement in median survival compared with T-DM1 alone

110 ogress in health therapy makes a significant improvement in natural nutraceuticals.

111 uals in both treatment groups showed similar improvement in NEI-VFQ-25 scores after 3 years of follow

112 These events likely underpin the improvement in oocyte quality achieved by using the FLI

113 h an intermediate level of experience showed improvement in OR performance score.

114 (LPS) or leiomyosarcoma showed a significant improvement in overall survival (OS) for the eribulin ar

115 tervention group reported significantly more improvement in pain (mean difference, 1.6 units [95% CI,

116 on treatment are associated with functional improvement in patients with HF and reduced ejection fra

117 A statistically significant improvement in PDT mediated efficacy (p<0.001) was also

118 ks, patients continued on anakinra showed an improvement in peak Vo2 from 14.5 (10.5-16.6) mL/kg per

119 t stimulation group demonstrated significant improvement in performance at 24 h post-transcranial dir

120 gnitive characteristics were associated with improvement in placebo conditions.

121 RMALINE-MM1 study demonstrated a significant improvement in progression-free survival (PFS) with ixaz

122 Mean prebronchodilator FEV1 showed improvement in responders at 6 months, while a decrease

123 ment of green banana flour (up to a fivefold improvement in RS performance).

124 Moreover, greater improvement in second/third interdigit cortical separati

125 The coprimary outcomes were improvement in severity of liver disease (change in MELD

126 Ammonia-lowering therapy results in improvement in skeletal muscle phenotype and function an

127 The improvement in specificity that DRELFA exhibits is an ad

128 training resulted in a small but significant improvement in speech comprehension, whereas donepezil h

129 d a significant reduction in virus titer and improvement in survival that is associated with pronounc

130 In addition, the magnitude of LDX-induced improvement in symptom severity predicted both direction

131 uction in the need for surgery and a greater improvement in symptoms than placebo.

132 ective with a >90% relief of obstruction and improvement in symptoms.

133 y, the resolution of which yielded a 25-fold improvement in taxadiene production.

134 We show that Lym1K leads to a significant improvement in the alignment of short read sequences fro

135 At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failu

136 microbiology departments, opportunities for improvement in the cultivation and management of highly

137 receptor (EGFR) have provided a significant improvement in the disease outcome of nonsmall cell lung

138 0 days that persisted to 1 year, with a mean improvement in the KCCQ-OS score of 27.6 (95% CI, 27.3-2

139 There was also no improvement in the rate of successful cardioversion afte

140 This was primarily related to an improvement in the time from PSC door in to door out tha

141 We also observed an improvement in thermostability and a reduction in CD4 af

142 nitiative identified 1 indicator: 10% annual improvement in third dose of diphtheria- tetanus-pertuss

143 ht scatter suspension might provide dramatic improvement in times to a result.

144 delay and residual symptoms and the lack of improvement in treatment delay during the study period h

145 with anti-VEGF injections showed significant improvement in VA at 1 year (mean logMAR VA improvement

146 ution spontaneously occurred in 20%, with an improvement in vision.

147 d delay in treatment is associated with less improvement in visual acuity (VA).

148 s compared with controls led to little to no improvement in weight over a period of about 12 months (

149 Our framework facilitates improvements in air pollution reduction strategies and l

150 We noted secular improvements in all postnatal growth parameters (except

151 eta-related pathology coupled with cognitive improvements in an AD APP/PS1 transgenic mouse model.

152 Improvements in ankle-brachial index, Rutherford class,

153 n sufficiently account for attention-related improvements in behavior.

154 g 52 or more hours of contact showed greater improvements in blood pressure than control groups: -6.4

155 rgy scenarios require significant efficiency improvements in both electricity generation and storage.

156 Improvements in care and treatment have led to more youn

157 -centered outcomes for childhood obesity and improvements in child BMI.

158 Despite broad improvements in clinical parameters, total bacteria and

159 s-corrected bootstrapping to examine whether improvements in coping mediated the effects of early pal

160 a analysis techniques has resulted in marked improvements in detection sensitivity and size resolutio

161 Surviving patients had, on average, large improvements in health status at 30 days that persisted

162 e at 30 days with low mortality, significant improvements in hemodynamic outcomes, and low incidence

163 However, over the last 3 decades, improvements in intrauterine interventions and perinatal

164 patients, 6-months of HD was associated with improvements in LV mass, strain and troponin.

165 the factors that can be used to explain the improvements in MAOS and how computational calculations

166 Clear improvements in measured detective quantum efficiency an

167 that delay treatment initiation and prevent improvements in morbidity and mortality.

168 mechanisms underlying behaviorally observed improvements in near-threshold odor detection and discri

169 These degeneration studies may propel improvements in nerve regeneration and draw critical par

170 tability, which combined to give significant improvements in oral exposure.

171 Drug-related improvements in OS were, however, widely distributed acr

172 dy of cardiovascular health is feasible, and improvements in participant diversity and engagement wil

173 ries (PHLs) are on the cusp of unprecedented improvements in pathogen identification, antibiotic resi

174 In order are to achieve meaningful improvements in patient safety, and create harm free env

175 Improvements in plant photosynthesis by genetic engineer

176 The improvements in potency directly correlated with target

177 Optimization of the ATC series gave improvements in potency, aqueous solubility, and metabol

178 Our study further suggests that improvements in primary somatosensory cortex somatotopy

179 CST resulted in greater improvements in QoL compared with heart failure educatio

180 HbA1c were more specific and provided modest improvements in risk discrimination for clinical complic

181 However, improvements in rubber yield and agronomically relevant

182 us early intervention services would lead to improvements in social recovery.

183 Improvements in stem cell culture methods, materials and

184 Improvements in symptom class (79% in New York Heart Ass

185 lowing verum acupuncture predicted sustained improvements in symptom severity at 3-month follow-up.

186 At day 90, there were also relative improvements in tear breakup time and ocular bulbar redn

187 2-fold increase in contig length and notable improvements in the assembly of intergenic spaces and ce

188 nce nanomaterials that will cause disruptive improvements in the field of biosensing.

189 ransplantation, both anatomic and functional improvements in the injured animals emerged over the cou

190 Remarkably, these learning-related improvements in the V1 representation were fully express

191 the procedure and may not be accompanied by improvements in threshold sensitivity or color discrimin

192 We observed learning-related improvements in V1 processing, which were fully expresse

193 to +42.2%), with 128 (61.6%) ACOs reporting improvements (incidence rate ratio, 1.04; 95% confidence

194 Recent improvements include extensive curation of additional re

195 These improvements included noise, sharpness, and ability to e

196 than SN at baseline, both groups improved on improvement index (>30%; false discovery rate [FDR] corr

197 ration Collaborative is a real-world quality improvement initiative being implemented across 76 ICUs

198 To investigate the impact of a quality improvement initiative for severe sepsis and septic shoc

199 This quality improvement initiative in sepsis in an emerging country

200 Future quality improvement initiatives should highlight the importance

201 is showed that the major contribution to the improvement is due to the optimized NBC combination of t

202 However, the absolute magnitude of improvement is not sufficient to justify its clinical us

203 t dominant model for radiologist performance improvement is scoring-based peer review, which reflects

204 the structures and processes behind observed improvements is needed to further reduce the burden of i

205 line disease severity, extent of therapeutic improvement, long-term influence of alcohol relapse, and

206 Despite this S/N improvement, mass measurement accuracy was noticeably im

207 Despite significant improvement, molecular and functional readouts were not

208 onnections reliably associated with clinical improvement (motor score of the Unified Parkinson Diseas

209 , engraftment, and led to robust motosensory improvement, neuropathic pain and tissue damage mitigati

210 In both treatment groups, most BCVA improvements occurred during the first 6 months and were

211 and similar percentage in study 2 had a BCVA improvement of >/=15 letters from preoperative baseline

212 6) at baseline and 1.79 (0.58) at 1 year, an improvement of -0.09 BMI z score units (95% CI, -0.13 to

213 improvement in VA at 1 year (mean logMAR VA improvement of 0.17 units, 95% confidence interval [CI],

214 ti-task model we observed an average F-score improvement of 0.8% when compared to the single-task mod

215 bsorption, with a maximum observed factor of improvement of 1.46.

216 of EBV and 6.5% of SoC subjects had an FEV1 improvement of 12% or more (P < 0.001).

217 ncreased or stayed the same, with an average improvement of 28% +/- 20% (scored on a scale of 0%-100%

218 Improvement of clinical outcome mainly relies on the dec

219 lethal mutation in mammals could facilitate improvement of diagnostics and therapeutics for affected

220 immune responses and suggest routes for the improvement of E "mimicry" by E1 by increasing its recog

221 ement device therapy was not associated with improvement of endothelial function compared with the sh

222 prevention of vascular oxidative stress and improvement of endothelial NO production represent reaso

223 Fragment-based drug discovery and continuous improvement of existing protein inhibitors rely on the k

224 Patients' self-reported improvement of hyperkeratosis was significantly greater

225 ed intracellular delivery results in 10-fold improvement of its cancer cell-killing efficacy.

226 erage at baseline, a mean placebo-associated improvement of less than 0.2 SD provides evidence that c

227 tes are greater than 95% in many centres but improvement of long-term function remains a challenge.

228 CCR2 deficiency does not provide sustained improvement of muscular dystrophy in mdx(5cv) mice.

229 onic effects together, showing a significant improvement of over 600%.

230 LVAD therapy resulted in improvement of patient health status in heart failure pa

231 s, and hence it provides a powerful tool for improvement of phosphorylation site prediction.

232 lities of engineering hormone cross talk for improvement of plant fitness and crop production.

233 d macrophages in the skin, although clinical improvement of scleroderma was only seen in one model.

234 The strategy for improvement of sensors used here should be applicable fo

235 ion in size of lesions as well as subjective improvement of symptoms.

236 esources for genetic studies and the genetic improvement of tambaqui exist.

237 ion and offers a starting point for targeted improvement of the colonization capabilities of plant-be

238 100 MPa-300 MPa indicate both a significant improvement of the composites creep resistance due to th

239 Additionally, it is of importance for future improvement of the crop, particularly in the light of cl

240 ch lower, therefore possibilities for future improvement of the detection limit are discussed.

241 adult mice and is associated with long-term improvement of tone-discrimination abilities.

242 tment of IBD with PRF results in significant improvements of clinical parameters compared to baseline

243 hat these changes translate into substantial improvement on multiple empirical datasets.

244 ith the input population size, a substantial improvement on previous implementations of probabilistic

245 The primary endpoint was a >/=50% improvement on the Pain Disability Index in 50% of patie

246 ls, some placebo-treated participants showed improvement on the SRS.

247 However, recent improvements on alternative pulse sequences provide attr

248 that functional outcomes after TBI can show improvement or deterioration up to two decades after inj

249 ed normal weight by 12 months, a significant improvement over a prescreening cohort of newborns with

250 us solids, and represents a greater than 50% improvement over any previously reported experimental va

251 approximately 860 microA cm(-2) , a fivefold improvement over the best previous comparable devices un

252 The Quality Payment Program is a substantial improvement over the negative adjustments under the repe

253 This would present a tremendous improvement over the present methods that excessively fo

254 The intervention group reported more improvement over time in sexual pleasure (EST1 = .32 and

255 At 6 months, improvement persisted in 1 patient in the placebo group

256 The lack of functional improvement post-TAVR was predicted by a mix of baseline

257 s part of a larger project on trauma quality improvement practices in Peru.

258 d traditional predictors, with a substantial improvement prediction of amputation with ACR (differenc

259 within the Veterans Affairs Surgical Quality Improvement Program (2000-2014) who underwent a subset o

260 ollege of Surgeons National Surgical Quality Improvement Program (2006-2012) were used to identify fe

261 a voluntary checklist-based surgical quality improvement program had a reduction in deaths after inpa

262 rospective, observational study of a quality improvement program studied 2420 patients 20 years or ol

263 rs Cancer Registry with the Surgical Quality Improvement Program to identify veterans having surgery

264 le susceptibility to bTB and enhance genetic improvement programmes aiming at controlling and eradica

265 nable, but in many cases the nature of these improvements remains unknown.

266 To our knowledge, this significant improvement results in the longest lifetime for such a b

267 tific trade-offs that arise in the field, to improvements scientists wish for.

268 This improvement seemed restricted to a group of responders t

269 An improvement tendency of all anterior keratometric values

270 ter total knee arthroplasty provided greater improvements than a monitored home-based program alone i

271 such in-depth analysis can offer conceptual improvements that may bring us closer to an effective va

272 We assessed discrimination improvement through c-statistics.

273 de in nutritional enhancement of foods, both improvements through breeding and through biotechnology

274 Continued improvement to 36-months postinjury was only present for

275 carbohydrates and oil, but requires genetic improvement to attain its agronomic potential.

276 In this study, we propose improvements to SeqKernel that follows two directions.

277 Significant improvements to the platform in yield and accuracy, coup

278 We also highlight how further improvements to these exciting technologies, based on th

279 Our complementary improvements to this EM framework are easily incorporate

280 total combined symptom plus medication score improvement versus placebo of 21% (95% CI, 11.0% to 30.4

281 Early health status improvement was greater with TAVR, but only among patien

282 dian age, 42 [range, 18-69] years), clinical improvement was observed in parallel with complete withd

283 tion (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-q

284 hen combined multiplicatively, a substantial improvement was seen (IQ-OR, 1.64; 95% CI, 1.36 to 1.97;

285 Overall survival improvement was similar in patients with squamous (HR 0.

286 With further improvements, we expect this technology to enable quanti

287 improvement, and 0.73 for predicting a large improvement were observed.

288 on improvement and integrated discrimination improvement were significant for all outcomes.

289 s, the predictors for the off-treatment eGFR improvement were the LdT treatment (odds ratio [OR], 3.9

290 C statistics, and integrated discrimination improvement were used to compare the sex-specific risk s

291 the rituximab group, where these meaningful improvements were also captured by video recordings.

292 Significant visual and refractive improvements were found 12 months after T-ionto CL, thou

293 These improvements were notably associated with a modulation o

294 All improvements were stable over time.

295 ts]) than the control group at 3 months, and improvements were sustained at 9 months (mean difference

296 during nontask listening sessions, cortical improvements were weak and uncorrelated with perceptual

297 tes correlated with participants' behavioral improvement when the expected feature was task-relevant.

298 to assess the durability of quality-of-life improvement with TAVR vs SAVR in this population.

299 The CAT-HF (Cardiovascular Improvements With MV-ASV Therapy in Heart Failure) trial

300 A significant improvement would indicate that LTM training maximizes t